Brief: Omega Diagnostics Sees FY EBITDA Loss To Be £2.0m
April 17 (Reuters) - Omega Diagnostics Group PLC
ODX.L :
* TRADING UPDATE
* EXPECTS TO REPORT FY REVENUES OF £7.5M FROM CONTINUING
OPERATIONS
* EBITDA LOSS FOR FY23 IS NOW EXPECTED TO BE APPROXIMATELY
£2.0M
Source text for Eikon: ID:nRSQ3409Wa
Further company coverage: ODX.L
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Cambridge Nutritional Sciences
See all newsBrief: Cambridge Nutrition Says Adj Ebitda Expected To Show Loss Of £0.4 Mln For Year Ended 31 March 2026
UK's Cambridge Nutritional Sciences yearly revenue as geopolitical turmoil delays overseas orders
Cambridge Nutrition. - Trading & Business Update
Cambridge Nutrition. - Holding(s) in Company
Cambridge Nutrition. - Holding(s) in Company